Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01447316 · ClinicalTrials.gov registry record

Bariatric Surgery on Short Term Weight Loss- Related Changes in Gait

A clinical trial of Obesity, Morbid, sponsored by University of Florida.

Completed
Registry status
36
Enrollment target
1
Study location

NCT01447316: Completed study of Obesity, Morbid, sponsored by University of Florida.

NCT01447316 is a study of Obesity, Morbid that has completed, run by University of Florida. The registered enrollment target is 36 participants, below the 101-participant average among 19 other Obesity, Morbid trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01447316, a study of Obesity, Morbid, has completed, sponsored by University of Florida.

COMPLETED
Registry status
36 participants
Enrollment target
1
Study location

Study Summary

This is a short term study of the effects of bariatric surgery on body composition, gait parameters during walking, lower extremity joint pain and quality of life (QOL) in morbidly obese patients who are already scheduled for a bariatric surgical procedure.

Primary Outcome

To track changes in body composition and mass during the study, body weight body fat mass, fat free mass will be collected prior to and 2 and 4 weeks after the bariatric surgery using air plethysmography. Air plethysmography (using the BOD POD®) is a reliable technique of body volume and composition, and has been validated for use in obese individuals and is highly correlated to the gold standard of body composition assessment, underwater weighing.

Conditions Studied

Interventions

  • OTHER Subject outcomes following bariatric surgery

Study Locations (1)

Florida

  • UF&Shands Orthopaedics and Sports Medicine Institute - Gainesville

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2009-08
Est. Completion 2013-01
University of Florida

1,106 total trials

What the finished NCT01447316 record still lists

NCT01447316 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 101-participant average among 19 other Obesity, Morbid trials with a reported enrollment target (64% lower).

The record links to 1 condition, with Obesity, Morbid appearing as the primary indexed condition, and to 1 intervention - of which Subject outcomes following bariatric surgery is the first listed.

NCT01447316 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT01447316 about?

NCT01447316 is a clinical study titled "Bariatric Surgery on Short Term Weight Loss- Related Changes in Gait". This is a short term study of the effects of bariatric surgery on body composition, gait parameters during walking, lower extremity joint pain and quality of life (QOL) in morbidly obese patients who are already scheduled for a bariatric surgical procedure.

What is the current status of trial NCT01447316?

This trial is currently completed. The enrollment target is 36 participants. The study started on 2009-08. Estimated completion is 2013-01.

What conditions does trial NCT01447316 study?

This clinical trial studies the following conditions: Obesity, Morbid.

What interventions are being tested in trial NCT01447316?

The interventions under investigation include: Subject outcomes following bariatric surgery (OTHER).

Who is sponsoring clinical trial NCT01447316?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01447316 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity, Morbid

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01447316's enrollment target sits among peer trials

36 10th of 19 higher than 10 of 19 other Obesity, Morbid trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity, Morbid trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01447316, the US trial registry maintained by the National Library of Medicine. NCT01447316 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.